Literature DB >> 16564795

Small ciliary body tumors: ultrasound biomicroscopic assessment and follow-up of 42 patients.

Daniel J Weisbrod1, Charles J Pavlin, Khaled Emara, Mark A Mandell, John McWhae, E Rand Simpson.   

Abstract

PURPOSE: Detecting and following small tumors of the ciliary body is a particular challenge because of their location. Recently high-frequency ultrasound biomicroscopy (UBM) has been used to assist in this task. The aim of this study was to evaluate this subset of small ciliary body tumors through the use of UBM.
DESIGN: Retrospective, noncomparative case series.
METHODS: Forty-two patients with small ciliary body tumors (less than 4 mm) from our institution were included in the study with a median follow-up of 4.3 years. UBM was used to assess tumor characteristics including height, location, and internal and external features. The data were collected longitudinally, and statistical analysis was performed.
RESULTS: Median initial tumor height was 2.05 mm (range 1.1 to 3.8 mm) as measured by UBM. By 5 years after diagnosis, five tumors (12%) exhibited growth. The overall mean growth rate was 0.026 mm per year (P = .00007). The most rapid period of growth was in the first year after diagnosis (growth rate 0.128 mm per year), after which the mean tumor size appeared to stabilize.
CONCLUSIONS: UBM is a valuable tool for detecting and following small ciliary body tumors (less than 4 mm), as these lesions may go undetected by other methods. Despite the potential for local extension into the iris or choroid, few of the tumors in this study exhibited growth, suggesting that many of these tumors can be managed conservatively. UBM can be used to assess various internal tumor features; however, arriving at a specific diagnosis without histologic correlation is difficult.

Entities:  

Mesh:

Year:  2006        PMID: 16564795     DOI: 10.1016/j.ajo.2005.11.006

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  8 in total

1.  A non-contiguous recurrence of the ciliary body melanoma-is cataract surgery a risk factor?

Authors:  Biljana Kuzmanović Elabjer; Mladen Bušić; Mirjana Bjeloš; Daliborka Miletić; Nenad Vukojević
Journal:  Int J Ophthalmol       Date:  2020-04-18       Impact factor: 1.779

2.  Ultrasound biomicroscopy in the management of retinoblastoma.

Authors:  L M Vasquez; G P Giuliari; W Halliday; C J Pavlin; B L Gallie; E Héon
Journal:  Eye (Lond)       Date:  2011-01-14       Impact factor: 3.775

3.  Characteristics of the Ciliary Body in Healthy Chinese Subjects Evaluated by Radial and Transverse Imaging of Ultrasound Biometric Microscopy.

Authors:  Jiawei Ren; Xinbo Gao; Liming Chen; Huishan Lin; Yao Liu; Yuying Zhou; Yunru Liao; Chunzi Xie; Chengguo Zuo; Mingkai Lin
Journal:  J Clin Med       Date:  2022-06-27       Impact factor: 4.964

4.  Ocular volumetry using fast high-resolution MRI during visual fixation.

Authors:  K Tanitame; T Sone; T Miyoshi; N Tanitame; K Otani; Y Akiyama; M Takasu; S Date; Y Kiuchi; K Awai
Journal:  AJNR Am J Neuroradiol       Date:  2012-10-04       Impact factor: 3.825

Review 5.  High-resolution ultrasound imaging of the eye - a review.

Authors:  Ronald H Silverman
Journal:  Clin Exp Ophthalmol       Date:  2008-12-09       Impact factor: 4.207

6.  Ciliary body melanoma with limited nodular extrascleral extension and diffuse iris-angle infiltration treated by whole anterior segment plaque radiotherapy.

Authors:  Michael E Gray; Zélia M Corrêa; James J Augsburger; William Barrett
Journal:  Int Ophthalmol       Date:  2007-04-28       Impact factor: 2.031

7.  Morphometric assessment of normal human ciliary body using ultrasound biomicroscopy.

Authors:  Yoshifumi Okamoto; Fumiki Okamoto; Shinichiro Nakano; Tetsuro Oshika
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-10-03       Impact factor: 3.117

8.  Crystalline Lens Resorption Caused by Ciliary Body Melanoma.

Authors:  William M Carrera; Matthew R Denny; Michael I Seider
Journal:  Case Rep Oncol       Date:  2020-05-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.